Navigation Links
Drug-Eluting Stents Ensure Patency Of The Saphenous Vein Grafts

The new generation stents that are deigned for slow release of medication are found to be far more effective than conventional stents according to a recent study conducted on stents used for cardiac bypass // . It is also found to effectively prevent the overgrowth of scar tissue, thereby reducing incidence of restenosis (re-narrowing), heart attack and death.

Stents can either be inserted into a grafted vein or into a native coronary artery during a balloon angioplasty procedure. The plague-clogged area is opened up by the balloon followed by which a stent is placed to keep the vessel patent.

Veins removed from the legs (saphenous veins) are used to replace clogged arteries in the heart (coronary arteries). However, these grafts become old over a period of time. Infact nearly 50% of all vein grafts become diseased, necessitating a second intervention in the form of either a repeat open-heart surgery or balloon angioplasty with a reinsertion of a stent within 5 to 10 years of first cardiac surgery.

Some of the causes for restenosis include build up of plaque, cholesterol debris and blood clots that hinder with the patency of the graft. The incidence of re-stenosis is much greater in the saphenous vein grafts compared with percutaneous interventional procedure involving the native coronary arteries. The new stents were found to reduce the risk of re-stenosis by as much as 4 times compared to commercially available stents.

Out of the 223 patients who underwent angioplasty for treatment of diseased saphenous vein grafts (placed 8 years ago), 139 patients had drug-eluting stents placed. The rest of them had conventional stents placed.

The incidence of heart attacks, the necessity to reopen a vein graft was considerably lower among those fitted with a drug eluting stent with the reduction rates approximating to 4 and 10 compared to 20 and 37 in those fitted with a conventional stent.

Previous studies have already established that medicated stents are effective in the prevention of scar tissue formation and narrowing in the coronary arteries, the study is the first of it’s kind to explore the effectiveness in saphenous vein grafts.

The researchers intend to continue the study to find if similar results would be obtained on a long-term basis.


'"/>




Related medicine news :

1. Stronger Backing for Drug-Coated Stents
2. Drug-Coated Stents – Proven to be More Effectiv
3. The Efficacy Of Newer Stents Questioned
4. Analyzing The Side Effects Of Sirolimus Stents
5. Stents That Release Medication To Check Artery Narrowing
6. Drug-Coated Stents Work Better In Diabetic Patients After Angioplasty
7. Effectiveness Of Drug-Releasing Coronary Stents
8. Nitiol Stents A Better Alternative for the Conventional Stents
9. Does Life Saving Stents Actually Carry The Risk Of Blood Clots?
10. Bottleneck for Neck Stents - May Enhance Risk of Stroke, Says a Study
11. Using Heart Stents Tends to Form More Clots
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/19/2017)... ... August 19, 2017 , ... ... is the first organization with pending recognition status from the Centers for Disease ... via group telehealth classes and live video conferencing. , The DPP resulted ...
(Date:8/19/2017)... ... 19, 2017 , ... Parker at Stonegate, an assisted living ... employees, caregivers, volunteers, thought leaders, researchers, educators and partners leading the way in ... to refresh the carpeting with the goal of maintaining the same precise colors ...
(Date:8/18/2017)... VA (PRWEB) , ... August 18, 2017 , ... More ... the Democratic Republic of Congo (DRC) thanks to an ambitious venture that conjoined the ... well as the generous support of the Liberty community. These shoes will save lives ...
(Date:8/18/2017)... NY (PRWEB) , ... August 18, 2017 , ... ... of this summer’s edition of “Vision & Hearing,” advocating for active, healthy lifestyles ... focuses on resources available for individuals with hearing impairments and shares the latest ...
(Date:8/18/2017)... ... August 18, 2017 , ... Hernandez Insurance Agencies, a northern ... the greater DC region, is inaugurating a “New Leash On Life” charity initiative ... training them to be companions for veterans in need. , The Semper K9 ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... OCEANSIDE, Calif. , Aug. 15, 2017  AOTI Inc. announced ... Advanced Oxygen Therapy Inc., has recently opened a New York City ... the ever-increasing usage of its unique Topical Wound Oxygen (TWO 2 ... approved by the Accreditation Commission for Health Care (ACHC) under the ... ...
(Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
(Date:8/7/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) today ... effective Aug. 7, 2017. ... interests and will serve as president emeritus during a planned, ... in multiple leadership roles since he joined Diplomat with the ... provided decisive, strategic leadership which continues to benefit our patients ...
Breaking Medicine Technology: